New York Life Investment Management »

Immunovant shares owned by New York Life Investment Management

Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by New York Life Investment Management from 13F filings

Historical chart of New York Life Investment Management investment in Immunovant

Tip: Access up to 7 years of quarterly data

All positions including Immunovant held by New York Life Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunovant by New York Life Investment Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $945k 22k 42.13
2023-09-30 $880k 23k 38.39
2023-06-30 $504k 27k 18.97
2023-03-31 $466k 30k 15.51
2022-12-31 $1.8M 103k 17.75
2022-09-30 $510k 91k 5.58
2022-06-30 $330k 85k 3.90

More positions owned by New York Life Investment Management

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Indexiq Etf Tr Candriam Us Larg (IQSU)
Amazon (AMZN)
Indexiq Active Etf Tr Iq Mackay Esg Cr (ESGB)
Indexiq Etf Tr Candriam Us Mid (IQSM)
Indexiq Etf Tr Iq 500 Int Etf (IQIN)
Indexiq Etf Tr Candriam Interna (IQSI)
Meta Platforms Cl A (META)
Ishares Tr Fltg Rate Nt Etf (FLOT)
Indexiq Etf Tr Iq U.s. Small Ca (CSML)
Alphabet Cap Stk Cl A (GOOGL)
Indexiq Etf Tr Iq Cbre Nexgen (ROOF)
Indexiq Etf Tr Ftse Internl Eqt (HFXI)

View all positions for New York Life Investment Management

Top funds holding Immunovant

Vanguard Group
Point72 Asset Management
Perceptive Advisors
T. Rowe Price Associates
Alpine Partners VI
Logos Global Management
Cormorant Asset Management
Citadel Advisors
Commodore Capital
Boxer Capital
Redmile Group
Fred Alger Management
Millennium Management
Dimensional Fund Advisors
Ikarian Capital

View all funds holding Immunovant